Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:approvedBy |
malaria vaccine
herpes zoster vaccine |
| gptkbp:component |
AS01 adjuvant system
|
| gptkbp:contains |
gptkb:QS-21
gptkb:MPL liposomes 3-O-desacyl-4'-monophosphoryl lipid A (MPL) saponin QS-21 |
| gptkbp:developedBy |
GlaxoSmithKline
|
| gptkbp:function |
enhances immunogenicity of vaccines
|
| https://www.w3.org/2000/01/rdf-schema#label |
AS01E adjuvant
|
| gptkbp:mechanismOfAction |
stimulates innate and adaptive immune response
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:usedIn |
gptkb:RTS,S/AS01_malaria_vaccine
gptkb:Shingrix_vaccine |
| gptkbp:bfsParent |
gptkb:Arexvy
|
| gptkbp:bfsLayer |
7
|